HUM HUMANA INC
Hospital & Medical Service Plans · NYSE · SEC CIK 49071 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $41.16B | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B |
| SG&A expense | $4.60B | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B |
| Operating income | $75.00M | $1.36B | $1.75B | -$808.00M | $400.00M | $1.10B | $2.01B | -$543.00M |
| Interest expense | $217.00M | $197.00M | $193.00M | $146.00M | $168.00M | $157.00M | $160.00M | $164.00M |
| Pretax income | $216.00M | $952.00M | $1.59B | -$1.13B | $134.00M | $741.00M | $1.69B | -$963.00M |
| Income tax | $40.00M | $238.00M | $395.00M | -$249.00M | -$86.00M | $179.00M | $406.00M | -$216.00M |
| Net income | $162.00M | $694.00M | $1.19B | -$796.00M | $195.00M | $545.00M | $1.24B | -$693.00M |
| EBITDA | $233.00M | $1.52B | $1.92B | -$644.00M | $573.00M | $1.28B | $2.20B | -$335.00M |
| EPS (basic) | 1.35 | 5.78 | 9.85 | — | 1.62 | 4.52 | 10.31 | — |
| EPS (diluted) | 1.33 | 5.73 | 9.83 | — | 1.62 | 4.51 | 10.30 | — |
| Dividends declared per share | 0.89 | 0.89 | 0.89 | 0.89 | 0.89 | 0.89 | 0.89 | 0.89 |
| Weighted avg. shares (diluted) | 121.83M | 121.14M | 120.65M | — | 120.75M | 120.75M | 120.84M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $6.93B | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B |
| Short-term investments | $18.17B | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B |
| Receivables | $2.87B | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B |
| Current assets | $39.61B | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B |
| PP&E, net | $2.07B | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B |
| Goodwill | $10.55B | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B |
| Intangibles | $1.18B | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B |
| Total assets | $57.28B | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B |
| Current liabilities | $24.05B | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B |
| Short-term debt | $949.00M | $2.27B | $1.72B | $0 | $0 | $0 | $577.00M | $577.00M |
| Long-term debt | $11.55B | $11.98B | $12.27B | $12.37B | $12.61B | $12.59B | $12.73B | $11.14B |
| Total debt | $12.50B | $14.25B | $13.99B | $12.37B | $12.61B | $12.59B | $13.31B | $11.72B |
| Total liabilities | $38.40B | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B |
| Shareholders' equity | $18.82B | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B |
| Net debt | $5.57B | $7.35B | $9.04B | $8.17B | $7.22B | $8.55B | $9.06B | $9.50B |
| Cash flow statement | ||||||||
| Operating cash flow | $2.16B | $1.97B | $1.25B | -$1.65B | $971.00M | $1.27B | $331.00M | -$528.00M |
| Capital expenditure | $137.00M | $132.00M | $121.00M | $202.00M | $135.00M | $114.00M | $95.00M | $154.00M |
| Free cash flow | $2.03B | $1.83B | $1.13B | -$1.85B | $836.00M | $1.16B | $236.00M | -$682.00M |
| Investing cash flow | -$2.07B | -$273.00M | -$2.55B | $632.00M | $980.00M | $347.00M | $314.00M | -$63.00M |
| Financing cash flow | -$52.00M | $249.00M | $2.05B | -$168.00M | -$603.00M | -$1.83B | $1.38B | -$2.30B |
| Depreciation & amortization | $158.00M | $159.00M | $163.00M | $164.00M | $173.00M | $178.00M | $183.00M | $208.00M |
| Stock-based compensation | $67.00M | $65.00M | $51.00M | $48.00M | $83.00M | $61.00M | $49.00M | $54.00M |
| Dividends paid | $106.00M | $107.00M | $107.00M | $109.00M | $107.00M | $106.00M | $108.00M | $108.00M |
| Share buybacks | $2.00M | $1.00M | $107.00M | $42.00M | $0 | $100.00M | $9.00M | $49.00M |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.